S01413 Summary:

BILL NOS01413
 
SAME ASSAME AS A02383
 
SPONSORRIVERA
 
COSPNSRADDABBO, GAUGHRAN, GOUNARDES, HINCHEY, HOYLMAN, KAMINSKY, KRUEGER, LIU, MAY, SALAZAR, SANDERS, SERRANO
 
MLTSPNSR
 
Amd §§3216, 3221 & 4303, Ins L
 
Lowers the cost sharing cap for insulin from one hundred dollars to thirty dollars.
Go to top    

S01413 Actions:

BILL NOS01413
 
01/12/2021REFERRED TO INSURANCE
03/01/20211ST REPORT CAL.477
03/02/20212ND REPORT CAL.
03/03/2021ADVANCED TO THIRD READING
03/22/2021PASSED SENATE
03/22/2021DELIVERED TO ASSEMBLY
03/22/2021referred to insurance
01/05/2022died in assembly
01/05/2022returned to senate
01/05/2022REFERRED TO INSURANCE
02/14/20221ST REPORT CAL.486
02/15/20222ND REPORT CAL.
02/16/2022ADVANCED TO THIRD READING
05/24/2022PASSED SENATE
05/24/2022DELIVERED TO ASSEMBLY
05/24/2022referred to insurance
Go to top

S01413 Committee Votes:

Go to top

S01413 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S01413 Memo:

Memo not available
Go to top

S01413 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          1413
 
                               2021-2022 Regular Sessions
 
                    IN SENATE
 
                                    January 12, 2021
                                       ___________
 
        Introduced  by  Sen.  RIVERA -- read twice and ordered printed, and when
          printed to be committed to the Committee on Insurance
 
        AN ACT to amend the insurance law, in relation to capping  cost  sharing
          for insulin
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subparagraph (B) of paragraph 15-a  of  subsection  (i)  of
     2  section  3216  of the insurance law, as amended by section 1 of part DDD
     3  of chapter 56 of the laws of 2020, is amended to read as follows:
     4    (B) Such coverage may be subject to annual deductibles and coinsurance
     5  as may be deemed appropriate by the superintendent and as are consistent
     6  with those  established  for  other  benefits  within  a  given  policy;
     7  provided  however, the total amount that a covered person is required to
     8  pay out of pocket for covered prescription insulin drugs shall be capped
     9  at an amount not to exceed [one hundred] thirty dollars  per  thirty-day
    10  supply,  regardless of the amount or type of insulin needed to fill such
    11  covered person's prescription and regardless of  the  insured's  deduct-
    12  ible, copayment, coinsurance or any other cost sharing requirement.
    13    § 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221
    14  of  the insurance law, as amended by section 2 of part DDD of chapter 56
    15  of the laws of 2020, is amended to read as follows:
    16    (B) Such coverage may be subject to annual deductibles and coinsurance
    17  as may be deemed appropriate by the superintendent and as are consistent
    18  with those  established  for  other  benefits  within  a  given  policy;
    19  provided  however, the total amount that a covered person is required to
    20  pay out of pocket for covered prescription insulin drugs shall be capped
    21  at an amount not to exceed [one hundred] thirty dollars  per  thirty-day
    22  supply,  regardless of the amount or type of insulin needed to fill such
    23  covered person's prescription and regardless of  the  insured's  deduct-
    24  ible, copayment, coinsurance or any other cost sharing requirement.

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD04974-01-1

        S. 1413                             2
 
     1    §  3.  Paragraph  2 of subsection (u) of section 4303 of the insurance
     2  law, as amended by section 3 of part DDD of chapter 56 of  the  laws  of
     3  2020, is amended to read as follows:
     4    (2) Such coverage may be subject to annual deductibles and coinsurance
     5  as may be deemed appropriate by the superintendent and as are consistent
     6  with  those  established  for  other  benefits  within  a  given policy;
     7  provided however, the total amount that a covered person is required  to
     8  pay out of pocket for covered prescription insulin drugs shall be capped
     9  at  an  amount not to exceed [one hundred] thirty dollars per thirty-day
    10  supply, regardless of the amount or type of insulin needed to fill  such
    11  covered  person's  prescription  and regardless of the insured's deduct-
    12  ible, copayment, coinsurance or any other cost sharing requirement.
    13    § 4. This act shall take effect immediately and  shall  apply  to  any
    14  policy or contract issued or renewed on or after January 1, 2022.
Go to top